BioSpace News Archive

Drug Development

TLC Announces Initiation of Phase III Pivotal Clinical Trial of TLC599 for the Treatment of Osteoarthritis Knee Pain

TLC announced the initiation of a Phase III clinical trial (“EXCELLENCE”) to evaluate the efficacy and safety of single as well as repeated doses of TLC599 in patients with osteoarthritis (OA) of the knee.

October 2, 2019
·
5 min read
European Society of Medical Oncology Congress Presentations Show B-Cell Vaccine Combinations Inhibit Cancer Growth in Preclinical Models

Imugene Limited announced two presentations by medical investigators at the European Society of Medical Oncology in Barcelona Spain showed combining its HER2 vaccines with PD1 vaccines reduced cancer growth in a number of standard preclinical models.

October 2, 2019
·
4 min read
Drug Development

Comprehensive Phase 1b HER-Vaxx Cancer Vaccine Results Presented at the European Society of Medical Oncology (ESMO) Congress

Imugene Limited, a clinical stage immuno-oncology company, announced comprehensive clinical data results from the Phase Ib clinical study of its HER-Vaxx anti-cancer vaccine were presented at the European Society of Medical Oncology in Barcelona, Spain held from 27 September to 1 October 2019.

October 2, 2019
·
4 min read
Business

TrakCel announces strategic partnership with WuXi AppTec Advanced Therapies for optimization of supply chain for cell and gene therapy treatments

Partnership combines global CDMO services with industry leading cellular orchestration platform

October 2, 2019
·
5 min read
Policy

CELLINK granted design patent for BIO X

CELLINK is receiving a patent from the U.S. Patent and Trademark Office for the design of the company’s flagship bioprinter.

October 2, 2019
·
1 min read
Deals

uBiome to Close Doors One Month After Bankruptcy Filing

Less than one month after filing for bankruptcy, beleaguered Bay Area microbiome company uBiome is now shutting its doors and selling off assets.

October 2, 2019
·
2 min read
·
Alex Keown
Think You Might Be Terminated Soon? Know Your Employment Law Rights!

To learn more about employment law rights, we interviewed attorney J. Daniel Cole. Daniel provided key insights regarding an organization’s legal obligations and what you can do if you think you are being set up to be fired.

October 2, 2019
·
6 min read
·
Porschia Parker
Business

Stephen Hahn is Front-Runner to Take Over the FDA, Reports Say

According to multiple reports, President Donald Trump is set to pick Hahn, a noted radiation oncologist, as the successor to Scott Gottlieb.

October 2, 2019
·
2 min read
·
Alex Keown
Business

Biogen Shakes Up Leadership Team, R&D Head Departs for New Role

After multiple failures to develop therapeutics for Alzheimer’s disease, Biogen’s Michael D. Ehlers has resigned from his role as head of research and development.

October 2, 2019
·
3 min read
·
Alex Keown
Early Research Could Lead the Way to a Universal Cancer Vaccine

Hopes for a universal cancer vaccine received a boost from a new antigen discovery made by researchers at Arizona State University’s Biodesign Institute.

October 2, 2019
·
2 min read
·
Alex Keown